Skip to ContentSkip to Navigation
About us Faculty of Law Research Centres of Expertise Groningen Centre for Health Law
Header image Groningen Centre for Health Law
Voices in the Field

Voices in the Field: Dr Tankred Stoebe

Date:22 July 2017
Author:GHLG Blog

Interview conducted  April 15th 2017 by Helena Lindemann. Photo by Barbara Sigge.

Voices in the Field

Voices in the Field: Ellen ‘t Hoen

Date:01 July 2017
Author:GHLG Blog

Ellen ‘t Hoen is a lawyer and public health advocate with over 30 years of experience working on pharmaceutical and intellectual property policies. She has also published widely, her latest book being “Private Patents and Public Health: Changing...

The Most Common Misunderstanding About Compulsory Licences

Date:01 June 2017
Author:GHLG Blog
The belief that a country can only use compulsory licensing in cases of public health emergencies is a myth that has proven difficult to bust.

Seeking a French-speaking legal researcher for short-term case study (June-July 2017)

Date:30 May 2017
Author:GHLG Blog

Seeking legal research experience? Fluent in French? Interested in human rights and health?

A New Access to Medicines Initiative: Medicines Law & Policy

Date:26 May 2017
Author:GHLG Blog
This week during the WHO’s 70th World Health Assembly, GHLG member Ellen ‘t Hoen announced the launch of the new website, ‘Medicines Law & Policy’, established with colleagues Pascale Boulet and Kaitlin Mara, all experts in intellectual property and access to medicines. ML&P provides expertise in the form of policy and legal analyses, best practice models, and other information to work toward the goal of ensuring the availability of effective, safe, and affordable medicines for all.

Vision for sustainable access to innovative medicines: GHLG & UMCG’s Global Health Unit respond to the OECD

Date:11 May 2017
Author:GHLG Blog
Excessively high prices of innovative medicines threaten patient access and health system sustainability in developing and industrialised countries alike. The Organisation for Economic Co-operation and Development (OECD) has launched a new initiative to facilitate high-level dialogue between stakeholders on access to innovative medicines and the sustainability of prices. On April 30, 2017, members of the GHLG Research Centre and the Global Health Unit in the Dept. of Health Sciences at the University Medical Centre Groningen responded to OECD’s online consultation for sustainable access to innovative medicines. Below are excerpts from our response.

The Italian Exception: A personalised approach to accessing high-priced patented medicines

Date:10 May 2017
Author:GHLG Blog
At the end of March 2017, the Italian Minister of Health Beatrice Lorenzin authorised the importation of generic medicines. She did this with only a veiled reference to the high-priced hepatitis C (HCV) medicine sofosbuvir, marketed under the trade name Sovaldi. However, the authorisation is not restricted to the treatment of HCV and can be used to find alternatives for any medicine not available or affordable in Italy.

Monitoring needed for improving access to health care of irregular migrants

Date:02 May 2017
Author:GHLG Blog
Irregular migrants face obstacles when trying to obtain health care. In order to enjoy the right to health, it is necessary to create a central reporting point to monitor actual obstacles in the access of health care of irregular migrants.
Voices in the Field

Voices in the Field: Dr. Adriaan van Es

Date:25 April 2017
Author:GHLG Blog
Dr van Es is also active in health related human rights advocacy.  Learn more from the video below as part of our interview series, Voices in the Field*
Voices in the Field

Voices in the Field: Robert Simons

Date:16 April 2017
Author:GHLG Blog
In the following video, Simons joins Voices in the Field* to discuss his time working in a Sudanese refugee camp and with Romanian political prisoners, and to share one important message with colleagues and decision makers.
Share this Facebook LinkedIn